Research Library
RETA / IGF-1 LR3 research
6 articles to explore, with links to 11 original sources.
About RETA / IGF-1 LR3
This blend combines RETA and IGF-1 LR3 in the listed Heritage amounts for laboratory research.
Understand the science
What growth-factor binding proteins change in a laboratory experiment
Retatrutide activates GIP, GLP-1 and glucagon receptors and remains investigational. IGF-1 LR3 is a modified, extended form of insulin-like growth factor 1. An older experiment in cultured ovarian support cells shows why the modified form is treated as its own research material.
2 sources (1992, 2026)
Explore study findings
What a retatrutide outcomes trial can establish about kidney events
Retatrutide is an investigational peptide that acts on GIP, GLP-1 and glucagon receptors. IGF-1 LR3 is an engineered, extended version of the insulin-like growth factor 1 protein. This catalog entry names the two together.
3 sources (1995–2026)
Check methods and identity
What the lab would have to verify about a preparation with both molecules
Retatrutide is an investigational peptide with activity at GIP, GLP-1 and glucagon receptors. IGF-1 LR3 is an engineered insulin-like growth factor protein. Research about making each material provides background for asking how scientists would verify a preparation containing both.
3 sources (2023, 2026)
Interpret the evidence
Why glucose averages leave a combination safety question open
Retatrutide is an investigational peptide that activates GIP, GLP-1 and glucagon receptors. IGF-1 LR3 is a modified growth-factor protein with an extended amino-acid sequence.
3 sources (1997–2026)
What a different retatrutide combination taught researchers about study design
Retatrutide is an investigational GIP, GLP-1 and glucagon receptor agonist. IGF-1 LR3 is a modified, extended insulin-like growth factor protein. The exact pair in this entry is separate from a 2026 rat experiment that tested retatrutide with cagrilintide, an amylin-based peptide.
2 sources (1992, 2026)
Why a body scan leaves a separate question about muscle function
Retatrutide is an investigational peptide that activates GIP, GLP-1 and glucagon receptors. IGF-1 LR3 is an engineered form of insulin-like growth factor 1. An older retatrutide substudy used body scans to distinguish changes in fat from changes in lean tissue.
2 sources (1997, 2025)
